Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations.

Conclusion: In CLL, serum syndecan-1 (sCD138) levels at presentation correlate with disease burden, and higher baseline levels may predict early treatment. PMID: 30310786 [PubMed]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research